RAPIBLYK

Serial Number 98589242
748

Registration Progress

Application Filed
Jun 6, 2024
Under Examination
Mar 18, 2025
Approved for Publication
Jan 21, 2025
Published for Opposition
Jan 21, 2025
Registered

Trademark Image

RAPIBLYK

Basic Information

Serial Number
98589242
Filing Date
June 6, 2024
Published for Opposition
January 21, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
748
Status Date
Oct 10, 2025
Application
Pending
Classes
005

Rights Holder

AOP Orphan Pharmaceuticals GmbH

99
Address
Leopold-Ungar-Platz 2
Vienna 1190
AT

Ownership History

AOP Orphan Pharmaceuticals GmbH

Original Applicant
99
Vienna AT

AOP Orphan Pharmaceuticals GmbH

Owner at Publication
99
Vienna AT

Legal Representation

Attorney
Michael Fedrick

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

12 events
Date Code Type Description Documents
Oct 10, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 10, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
May 9, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
May 9, 2025 IUAF S USE AMENDMENT FILED Loading...
Mar 18, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 21, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 21, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 15, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 23, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 17, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 14, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 6, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical and veterinary preparations, namely, cardiovascular treatment preparations acting on the cardiovascular system and CNS; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of tachyarrhythmias, tachycardias and atrial fibrillation; pharmaceutical preparations for the emergency treatment of tachyarrhythmias, tachycardias and atrial fibrillation
First Use Anywhere: May 9, 2025
First Use in Commerce: May 9, 2025

Classification

International Classes
005